The event will bring together leading academic and industry experts to discuss the current state of play in the ATMP landscape, along with the challenges and the way forward.
This conference brings together stakeholders in the orphan drugs industry to discuss and network with top tier government, pharmaceuticals, biotechs, non-profit organisations, orphan drug developers, research organisations as well as patients groups and advocates.
The EBMT Scientific Council, together with the local organising committee, has designed an outstanding programme to cover key issues relating to HSCT and cellular therapy research. The programme is made up of more than 170 sessions and 300 speakers.
This bespoke course, designed in collaboration with the industry's leading Advanced Therapy Medicinal Products (ATMP) manufacturers, aims to provide comprehensive training for practitioners working in Advanced Therapy Medicinal Products manufacturing.